NEW YORK, Aug 15 – DeCode of Reykjavik, Iceland reported a 62 percent increase in second-quarter revenues, which rose to $6.2 million, compared with $3.8 million in the year ago period, as the company received increased milestone payments from its drug discovery collaboration with Roche. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Gene drives might run into biological resistance, the Economist reports.

Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.

Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.

In Science this week: full CRISPR locus integration complex structure, and more.